97. Ulcerative colitis Clinical trials / Disease details


Clinical trials : 2,527 Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2010-019558-42-SK
(EUCTR)
23/02/201127/10/2010A Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety, and Tolerability of Baminercept in Subjects With Moderate to Severe Ulcerative ColitisA Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety, and Tolerability of Baminercept in Subjects With Moderate to Severe Ulcerative Colitis Ulcerative Colitis
MedDRA version: 12.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: Baminercept
Product Code: BG9924
INN or Proposed INN: N/A
Other descriptive name: Baminercept
Biogen Idec Ltd.NULLNot RecruitingFemale: yes
Male: yes
100Phase 2Hungary;Czech Republic;Slovakia;Belgium
2EUCTR2010-019558-42-HU
(EUCTR)
20/01/201110/11/2010A Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety, and Tolerability of Baminercept in Subjects With Moderate to Severe Ulcerative ColitisA Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety, and Tolerability of Baminercept in Subjects With Moderate to Severe Ulcerative Colitis Ulcerative Colitis
MedDRA version: 12.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: Baminercept
Product Code: BG9924
INN or Proposed INN: N/A
Other descriptive name: Baminercept
Biogen Idec Ltd.NULLNot RecruitingFemale: yes
Male: yes
100Hungary;Czech Republic;Belgium
3EUCTR2010-019558-42-CZ
(EUCTR)
10/01/201125/10/2010A Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety, and Tolerability of Baminercept in Subjects With Moderate to Severe Ulcerative ColitisA Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety, and Tolerability of Baminercept in Subjects With Moderate to Severe Ulcerative Colitis Ulcerative Colitis
MedDRA version: 12.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: Baminercept
Product Code: BG9924
INN or Proposed INN: N/A
Other descriptive name: Baminercept
Biogen Idec Ltd.NULLNot RecruitingFemale: yes
Male: yes
100Hungary;Czech Republic;Belgium
4EUCTR2010-019558-42-BE
(EUCTR)
23/12/201013/10/2010A Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety, and Tolerability of Baminercept in Subjects With Moderate to Severe Ulcerative ColitisA Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety, and Tolerability of Baminercept in Subjects With Moderate to Severe Ulcerative Colitis Ulcerative Colitis
MedDRA version: 12.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: Baminercept
Product Code: BG9924
INN or Proposed INN: N/A
Other descriptive name: Baminercept
Biogen Idec Ltd.NULLNot RecruitingFemale: yes
Male: yes
100Hungary;Czech Republic;Belgium